Latest News
Royal Caribbean Buys the Beach as Norwegian Fixes the Shipmarketbeat.com
Royal Caribbean and Norwegian both beat Q3 earnings estimates, but diverge for 2027: RCL pursues a $3 billion Sandals resort stake while NCLH focuses on cost cuts and debt reduction.
Via MarketBeat · November 2, 2026
Beta Technologies Beat Archer and Joby to an FAA First. Here's Why I'd Still Rather Own Archer.fool.com
Beta Technologies has beat Archer to the punch. So why choose Archer stock over Beta?
Via The Motley Fool · November 2, 2026
The Biggest Crypto Hack in History Just Happened. Here's What the $6.3 Billion Breach Means for the Crypto Market.fool.com
Binance's exchange just got hacked, and it's just the latest and biggest breach to hit crypto.
Via The Motley Fool · November 2, 2026
Federal Realty: 3 Key Takeaways for Long-Term Investorsfool.com
Signed leases worth 270 basis points of future rent are already locked in, setting up built-in revenue growth for next year.
Via The Motley Fool · November 2, 2026
Baker Hughes Co (NASDAQ:BKR): A Balanced Dividend Quality Pick for Income Investorschartmill.com
Via Chartmill · November 2, 2026
NAPCO Security Technologies (NASDAQ:NSSC) Stock Falls After Fiscal Q1 Revenue and EPS Misschartmill.com
Via Chartmill · November 2, 2026
United Parcel Service's Earnings Declined in Q3. Is the Dividend Still Safe?fool.com
The company's adjusted per-share profit was $1.69 last quarter, only slightly higher than the rate of its quarterly dividend.
Via The Motley Fool · November 2, 2026
My Top 3 AI Stock Picks for Novemberfool.com
2026 may be coming to a close, but there are some fantastic stocks that warrant buying right now.
Via The Motley Fool · November 2, 2026
Buy, Sell, or Hold Alphabet Stock After Its $505 Billion Meltdown?fool.com
Brace for more volatility as Alphabet's cash burn accelerates.
Via The Motley Fool · November 2, 2026
Marriott International (NASDAQ:MAR) Q3 Profit Beat Outshines In-Line Revenuechartmill.com
Via Chartmill · November 2, 2026
Axsome Therapeutics (NASDAQ:AXSM) Q3 2026 Earnings: In-Line Revenue, Narrower Loss, but Shares Slidechartmill.com
Via Chartmill · November 2, 2026
FOX (NASDAQ:FOXA) reports strong Q3 CY2026
Cable news and media network Fox (NASDAQ:FOXA) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q1 2027), with revenue up 22.3% year on yea...
Via StockStory · November 2, 2026
A $1,000 Investment in VYMI Today Could Become $14,632 in 25 Yearsfool.com
High-yield dividend stocks tend to grow more slowly than major tech names, but often more steadily.
Via The Motley Fool · November 2, 2026
Titan: 3 Key Takeaways for Long-Term Investorsfool.com
Lean dealer inventory means demand rebounds translate directly into factory orders, positioning Titan to capitalize quickly when agricultural markets stabilize.
Via The Motley Fool · November 2, 2026
SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDiskmarketbeat.com
SK hynix posted record Q3 revenue and added long-term AI customer contracts, while Micron and SanDisk also disclosed multiyear agreements shaping memory chip supply and pricing through 2030.
Via MarketBeat · November 2, 2026
Intel Stock Cratered 28%, Opening a Massive Buying Opportunity for Investors Looking for a Stock That Could Nearly Doublefool.com
Intel's post-earnings slide is an opportunity for investors to buy a potential long-term winner at an attractive valuation.
Via The Motley Fool · November 2, 2026
3 Bank Stocks With Buyback Plans of at Least $30 Billion Worth a Lookfool.com
JPMorgan, Bank of America, and Citigroup all have big stock buyback programs. Here's how they compare.
Via The Motley Fool · November 2, 2026
CME vs. SoFi Technologies: Which Financial Stock Is a Better Buy for 2027?fool.com
CME boasts a fortress balance sheet and a 62% net margin, while SoFi is burning cash but growing revenue 28.8% annually, a classic stability-versus-growth showdown.
Via The Motley Fool · November 2, 2026
UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case.fool.com
Trial results for its weight loss drugs could justify a higher valuation for the clinical-stage biotech.
Via The Motley Fool · November 2, 2026
W&T Offshore: 3 Key Takeaways for Long-Term Investorsfool.com
Low-cost workovers and disciplined capital allocation are positioning the company to fund acquisitions rather than chase production growth.
Via The Motley Fool · November 2, 2026
Premarket Movers Nov. 2, 2026: Gainers and Loserschartmill.com
Via Chartmill · November 2, 2026
Meet the Spectacular Vanguard ETF With 44.6% of Its Portfolio Parked in Nvidia, Alphabet, Apple, and Microsoftfool.com
The Vanguard Morningstar Mega Cap Growth ETF has crushed the S&P 500 since its inception in 2007.
Via The Motley Fool · November 2, 2026
Growing Expectations for a Midterm Election "Blue Wave" Holds 2 Risks for the 2nd Priciest Stock Market in Historyfool.com
Although stocks have historically thrived regardless of which party is in power, Wall Street’s No. 1 catalyst is at risk if Congress is divided.
Via The Motley Fool · November 2, 2026
STMicroelectronics Could Reach New Highs—Here's What Needs to Happenmarketbeat.com
STMicroelectronics posted Q3 revenue up 17.9% and strong Q4 guidance, with analysts maintaining a Moderate Buy rating and seeing 50% upside for STM shares.
Via MarketBeat · November 2, 2026
Marvell To Buy Lumentum For $115 Billion, Creating AI Connectivity Leaderinvestors.com
Marvell Technology on Monday announced a deal to buy Lumentum in an all-stock transaction worth $115 billion.
Via Investor's Business Daily · November 2, 2026